Side-by-side comparison of AI visibility scores, market position, and capabilities
AI-powered loyalty and customer engagement platform for enterprise retail. Based in Bangalore and Singapore.
Capillary Technologies is an AI-powered loyalty and customer engagement platform headquartered in Bangalore, India with a significant presence in Singapore. Founded in 2008, Capillary has grown into one of Asia's leading loyalty and CRM technology providers, serving over 400 enterprise brands across retail, hospitality, fuel retail, and consumer goods. The company's platform manages billions of loyalty transactions annually across markets in Asia-Pacific, the Middle East, and beyond. Capillary raised over $100M in funding and has established itself as the go-to loyalty infrastructure for large brands operating in emerging and high-growth markets.\n\nCapillary's product suite encompasses loyalty program management, customer data platform (CDP) capabilities, AI-driven personalization, and omnichannel campaign management. Its Loyalty+ module supports points, tiers, coalition programs, and gamified mechanics, while its Insights+ module provides real-time segmentation and predictive analytics to optimize engagement campaigns. The platform's AI layer powers personalized offer recommendations and next-best-action decisioning, helping brands increase repeat purchase rates and average order values. Capillary also offers a Anywhere Commerce module for headless ecommerce and order management.\n\nCapillary Technologies serves marquee clients including Puma, Levi's, Shell, Pizza Hut, and Marks & Spencer across more than 30 countries. Its deep expertise in emerging market retail—where cash-heavy, fragmented, and mobile-first commerce environments require flexible program design—differentiates it from Western-centric loyalty platforms. Capillary competes with Antavo, Salesforce Loyalty Management, and regional players, leveraging its Asia-Pacific depth, multilingual capabilities, and AI-native architecture to win complex, multi-market enterprise deals.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.